C
Originally published by Capital Newstop
January 27, 2026
5h ago
KUTRRH introduces groundbreaking prostate cancer therapy in East Africa

KUTRRH becomes the first public hospital in East Africa to offer Lutetium-177 PSMA therapy, a targeted treatment for advanced prostate cancer with fewer side effects...
✨ Key Highlights
The Kenyatta University Teaching, Referral and Research Hospital (KUTRRH) has become the first public hospital in East Africa to offer Lutetium-177 PSMA therapy for prostate cancer.
- This innovative treatment delivers radiation directly to cancer cells, offering new hope for patients with advanced prostate cancer who no longer respond to conventional therapies.
- Dr. Zeinab Gura, CEO of KUTRRH, highlighted this as a commitment to world-class, accessible cancer care.
- The introduction of this therapy supports Universal Health Coverage (UHC) and strengthens the region’s capacity to manage complex cancers.
Continue Reading
Read the complete article from Capital News
Advertisement
Related News
Advertisement





